Frontiers in Immunology (Dec 2023)

Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis

  • Kunwadee Noonong,
  • Kunwadee Noonong,
  • Moragot Chatatikun,
  • Moragot Chatatikun,
  • Sirirat Surinkaew,
  • Sirirat Surinkaew,
  • Manas Kotepui,
  • Rahni Hossain,
  • Kingkan Bunluepuech,
  • Chanittha Noothong,
  • Aman Tedasen,
  • Aman Tedasen,
  • Wiyada Kwanhian Klangbud,
  • Wiyada Kwanhian Klangbud,
  • Motoki Imai,
  • Motoki Imai,
  • Fumitaka Kawakami,
  • Fumitaka Kawakami,
  • Fumitaka Kawakami,
  • Makoto Kubo,
  • Makoto Kubo,
  • Makoto Kubo,
  • Yoshimasa Kitagawa,
  • Hiroshi Ichikawa,
  • Takuro Kanekura,
  • Suriyan Sukati,
  • Voravuth Somsak,
  • Voravuth Somsak,
  • Lunla Udomwech,
  • Takafumi Ichikawa,
  • Takafumi Ichikawa,
  • Veeranoot Nissapatorn,
  • Veeranoot Nissapatorn,
  • Jitbanjong Tangpong,
  • Jitbanjong Tangpong,
  • Hiroko P. Indo,
  • Hiroko P. Indo,
  • Hideyuki J. Majima,
  • Hideyuki J. Majima

DOI
https://doi.org/10.3389/fimmu.2023.1275001
Journal volume & issue
Vol. 14

Abstract

Read online

SignificanceThis review discusses the coronavirus disease 2019 (COVID-19) pathophysiology in the context of diabetes and intracellular reactions by COVID-19, including mitochondrial oxidative stress storms, mitochondrial ROS storms, and long COVID.Recent advancesThe long COVID is suffered in ~10% of the COVID-19 patients. Even the virus does not exist, the patients suffer the long COVID for even over a year, This disease could be a mitochondria dysregulation disease.Critical issuesPatients who recover from COVID-19 can develop new or persistent symptoms of multi-organ complications lasting weeks or months, called long COVID. The underlying mechanisms involved in the long COVID is still unclear. Once the symptoms of long COVID persist, they cause significant damage, leading to numerous, persistent symptoms.Future directionsA comprehensive map of the stages and pathogenetic mechanisms related to long COVID and effective drugs to treat and prevent it are required, which will aid the development of future long COVID treatments and symptom relief.

Keywords